close
close
Sun. Jul 14th, 2024

Newsweek hosts a panel on the future of life sciences at the 2024 BIO Convention

By Vaseline May30,2024

We are in the midst of a historic moment in the life sciences industry. After an initial wave of interest during the coronavirus pandemic, the healthcare and pharmaceutical industries saw a drastic drop in investment.

However, since early 2024, the tides have turned once again, as innovations in AI, personalized medicine and gene-based therapies promise to revolutionize the life science industry.

To delve deeper into these developments, Newsweek will host a panel discussion at the upcoming BIO International Convention in San Diego on June 3. This is one of the largest, most comprehensive events for the biotech industry, attended by more than 20,000 industry leaders from around the world.

Newsweeks During the affiliate event, Senior Science Reporter Pandora Dewan joins five industry experts to discuss the promise and challenges of these future innovations and, most importantly, how to deliver them to those who need them.

Newsweek is deeply committed to facilitating inspiring conversations that promote respectful debate and welcome diverse opinions,” said Dev Pragad, Newsweek CEO, said. “Our goal is to drive meaningful change across industries, and I am particularly excited about the transformative power of life sciences, especially within the biotech and pharmaceutical industries.

“These fields offer transformative potential for global healthcare and innovation, and we see significant opportunities for them Newsweek to contribute to public discourse and education on these developments,” Pragad added.

The event also marks the launch of Newsweeks annual report, The New Era of Life Sciences, featuring industry insights from the CEOs of Pfizer, Regeneron, Eli Lilly and others.

The panel will consist of:

  • Anna Windle, Senior Vice President of Clinical, Medical and Regulatory Affairs at Novo Nordisk.
  • Arda Ural, leader for the U.S. health sciences and wellness industry markets at Ernst & Young LLP.
  • Dr. Jenelle Krishnamoorthy, vice president and head of Global Public Policy at Merck.
  • Matthew Hewitt, vice president and technical officer, CGT and Biologics at Charles River Laboratories.
  • Dr. Karim Budhwani, CEO scientist at CerFlux.
Line-up for BIO 2024
Speaker line-up for Newsweek’s breakfast panel in conjunction with the 2024 BIO International Convention.

Amit Shah, Newsweeks SVP of Finance and Managing Director of Europe, Middle East and Africa, who chaired the event, described it as a “game-changer” for small and medium-sized businesses and entrepreneurs. “It is a platform where they can amplify their voices, connect with experts and reach a large audience Newsweek.”

Shah added, “Let us empower and inspire each other to achieve greater heights in the exciting realm of science!”

The panel will take place on Monday, June 3 at 1:00 PM EST. The in-person attendance is fully booked, but you are available to view the panel at Newsweeks YouTube channel after the event.